Imricor (IMR) is held by 2 ASX ETFs. Over the last year it fell 6.4%: on $10,000, −$644. We explain 9 big moves in that time.
About IMR
- SectorHealth Care
- IndustryHealth Care Equipment & Services
- Size$520.0m
- Held by2 ETFs
- Big moves9 in 1Y
Each dot is a move we explain. Tap one, or a row of Why it moved, to see what caused it.
Why it moved
- +3.1%peak +6.7%18 Sep 2026· Regulatory
Imricor Medical Systems rose as investor interest built ahead of an anticipated US regulatory approval, supported by a new securities quotation filing that signals a recent capital raise settling into the market.
- −0.5%peak +2.4%14 Aug 2026· Regulatory
Imricor Medical Systems rose after news it submitted its final 510(k) devices, bringing its full US FDA product platform closer to regulatory clearance.
- +5.1%13 Aug 2026· Contract
Imricor Medical Systems submitted final 510(k) devices, moving its full US FDA product platform closer to commercialization.
- +12.5%2 Jul 2026· Regulatory
Imricor Medical Systems jumped after receiving FDA paediatric clearances for its NorthStar and diagnostic catheter, advancing its U.S. commercialisation strategy.
- +5.4%25 Mar 2026· Unknown
Insufficient evidence to determine the cause of the abnormal price movement.
- −5.8%16 Mar 2026· Unknown
Insufficient evidence to determine the cause of the price move.
- +10.5%29 Jan 2026· Regulatory
FDA cleared Imricor's NorthStar Mapping System, driving a sharp rally and re-rating.
- +17.1%12 Jan 2026· Regulatory
FDA approval for Imricor Medical ignited a sharp rally in its shares, driving an 8.5x multiple of the normal daily range.
- +12.1%4 Nov 2025· Contract
Imricor announced the first-in-human ischemic VT ablation successfully performed in iCMR, a major clinical milestone.
Held by 2 ETFs
Of every $10,000 in each fund, how much is in IMR today.